Asset Allocation

As of January 31, 2026.
Type % Net
Cash 0.32%
Stock 49.38%
Bond 36.95%
Convertible 0.00%
Preferred 7.25%
Other 6.11%
View Asset Allocation
Start Trial

Market Capitalization

As of January 31, 2026
Large 52.09%
Mid 12.76%
Small 35.15%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 89.36%    % Emerging Markets: 2.63%    % Unidentified Markets: 8.02%

Americas 87.54%
81.74%
Canada 5.73%
United States 76.02%
5.80%
Brazil 2.60%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.43%
United Kingdom 1.83%
2.60%
France 0.58%
Germany 0.00%
Ireland 0.24%
Italy 0.00%
Netherlands 0.00%
Switzerland 0.80%
0.00%
0.00%
Greater Asia 0.02%
Japan 0.00%
0.00%
0.01%
South Korea 0.01%
Taiwan 0.01%
0.00%
Unidentified Region 8.02%

Bond Credit Quality Exposure

AAA 0.00%
AA 46.20%
A 0.61%
BBB 1.09%
BB 11.84%
B 10.29%
Below B 0.78%
    CCC 0.66%
    CC 0.00%
    C 0.12%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 29.18%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
23.09%
Materials
3.63%
Consumer Discretionary
12.38%
Financials
5.52%
Real Estate
1.56%
Sensitive
53.44%
Communication Services
6.65%
Energy
15.36%
Industrials
12.83%
Information Technology
18.59%
Defensive
19.78%
Consumer Staples
1.78%
Health Care
13.34%
Utilities
4.66%
Not Classified
3.69%
Non Classified Equity
0.15%
Not Classified - Non Equity
3.54%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 53.74%
Corporate 14.64%
Securitized 1.19%
Municipal 0.00%
Other 30.43%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
8.21%
Less than 1 Year
8.21%
Intermediate
44.44%
1 to 3 Years
5.70%
3 to 5 Years
28.46%
5 to 10 Years
10.28%
Long Term
47.32%
10 to 20 Years
1.12%
20 to 30 Years
46.20%
Over 30 Years
0.00%
Other
0.03%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial